BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30605956)

  • 61. [Recent advance in tuberous sclerosis-related genes and their expression].
    Liu J; Piao YS; Lu DH
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):210-2. PubMed ID: 20450774
    [No Abstract]   [Full Text] [Related]  

  • 62. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
    Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
    Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Symptomatic kidney involvement in a child with tuberous sclerosis.
    Hergüner MO; Karabay-Bayazit A; Noyan A; Altunbaşak S; Anarat A
    Turk J Pediatr; 2004; 46(1):76-8. PubMed ID: 15074379
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical analysis of tuberous sclerosis complex complicated with renal angiomyolipoma: a report of 22 cases].
    Ting WY; Zhang YS; Li HZ; Zhang XB; Xu WF
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2056-8. PubMed ID: 24169285
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [IgA nephropathy - prognostic factors and treatment].
    Wieliczko M; Dylewska M
    Wiad Lek; 2016; 69(5):707-710. PubMed ID: 28033590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M; Banasik M; Watorek E; Falkiewicz K; Patrzałek D; Szyber P; Klinger M
    Transplant Proc; 2006; 38(1):101-4. PubMed ID: 16504675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
    Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
    Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Renal lesions in tuberous sclerosis].
    Schillinger F; Montagnac R
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S123-6. PubMed ID: 17373212
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.
    Kwiatkowski DJ; Palmer MR; Jozwiak S; Bissler J; Franz D; Segal S; Chen D; Sampson JR
    Eur J Hum Genet; 2015 Dec; 23(12):1665-72. PubMed ID: 25782670
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus.
    Höcker B; Knüppel T; Waldherr R; Schaefer F; Weber S; Tönshoff B
    Pediatr Nephrol; 2006 Oct; 21(10):1476-9. PubMed ID: 16721582
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hemorrhagic angiomyolipoma and tuberous sclerosis complex: a case report.
    Mirchandani GR; Kempton JE; Dainiak C; Kraus ML
    Conn Med; 2002 Aug; 66(8):451-5. PubMed ID: 12407954
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tuberous sclerosis.
    Syed KN
    J Pak Med Assoc; 2010 Aug; 60(8):683-5. PubMed ID: 20726205
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    Asprino PF; Linck RDM; Cesar J; Freitas FP; Koyama FC; Riechelmann RSP; Costa FP; Hoff PMG; Galante PAF; Meyer D; Camargo AA; Sabbaga J
    Endocr Relat Cancer; 2018 Feb; 25(2):L1-L5. PubMed ID: 29167182
    [No Abstract]   [Full Text] [Related]  

  • 75. [Koenen, Kothe and peri-ungual fibroma in tuberous sclerosis].
    Borelli S
    Hautarzt; 1999 May; 50(5):368-9. PubMed ID: 10412636
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A diagnostic algorithm for enhanced detection of mosaic tuberous sclerosis complex in adults.
    Treichel AM; Kwiatkowski DJ; Moss J; Darling TN
    Br J Dermatol; 2020 Jan; 182(1):235-237. PubMed ID: 31287558
    [No Abstract]   [Full Text] [Related]  

  • 77. Symptomatic Periungual Fibroma of the Hand.
    Tang CQY; Chia AQX; Sechachalam S
    J Hand Microsurg; 2021 Jul; 13(3):173-177. PubMed ID: 34511834
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tuberous sclerosis.
    Gupta A; Singh SK; Phulambrikar T; Kumar S; Roy S
    J Clin Diagn Res; 2015 Apr; 9(4):ZJ01-2. PubMed ID: 26023662
    [No Abstract]   [Full Text] [Related]  

  • 79. [The 467th case: proteinuria, periungual fibromas, and facial steatadenomas].
    Chen G; Dong QR; Li MX; Li XM
    Zhonghua Nei Ke Za Zhi; 2019 Jan; 58(1):74-77. PubMed ID: 30605956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.
    Bissler JJ; Budde K; Sauter M; Franz DN; Zonnenberg BA; Frost MD; Belousova E; Berkowitz N; Ridolfi A; Christopher Kingswood J
    Nephrol Dial Transplant; 2019 Jun; 34(6):1000-1008. PubMed ID: 30053159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.